Joint (NASDAQ:JYNT) Stock Gets Price Target Trim from B. Riley Financial

Joint (NASDAQ:JYNT) had its price objective reduced by B. Riley Financial from $9.00 to $8.00 in a research report sent to investors on Monday,Benzinga reports. B. Riley Financial currently has a neutral rating on the stock.

A number of other brokerages also recently weighed in on JYNT. Wall Street Zen downgraded Joint from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Weiss Ratings cut Joint from a “sell (d+)” rating to a “sell (d)” rating in a report on Monday, October 26th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Joint currently has an average rating of “Reduce” and an average target price of $8.00.

Joint Stock Down 0.4%

JYNT stock opened at $6.80 on Monday. The firm has a market cap of $93.09 million, a price-to-earnings ratio of 29.70 and a beta of 1.16. The company’s fifty day simple moving average is $7.56 and its 200 day simple moving average is $8.48. Joint has a 12-month low of $6.52 and a 12-month high of $10.67.

Joint (NASDAQ:JYNT) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.02. The firm had revenue of $13.55 million during the quarter, compared to analyst estimates of $14.85 million. Joint had a return on equity of 22.11% and a net margin of 4.81%. Research analysts expect that Joint will post 0.31 earnings per share for the current year.

Institutional Investors Weigh In On Joint

Large investors have recently bought and sold shares of the stock. R Squared Ltd raised its holdings in shares of Joint by 40.3% during the third quarter. R Squared Ltd now owns 14,910 shares of the company’s stock valued at $110,000 after purchasing an additional 4,284 shares during the period. Strs Ohio grew its stake in shares of Joint by 17,300.0% in the 1st quarter. Strs Ohio now owns 17,400 shares of the company’s stock valued at $154,000 after buying an additional 17,300 shares during the period. Susquehanna International Group LLP grew its stake in shares of Joint by 161.3% in the 2nd quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock valued at $379,000 after buying an additional 26,626 shares during the period. Squarepoint Ops LLC grew its stake in shares of Joint by 35.5% in the 2nd quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock valued at $926,000 after buying an additional 27,633 shares during the period. Finally, Verus Capital Partners LLC increased its position in Joint by 23.6% in the 1st quarter. Verus Capital Partners LLC now owns 130,705 shares of the company’s stock valued at $1,157,000 after buying an additional 24,929 shares in the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

About Joint

The Joint Corp. (NASDAQ: JYNT) is a healthcare services company that operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company focuses on providing routine chiropractic care intended to support musculoskeletal health, mobility and general wellness. The Joint Chiropractic clinics offer services such as chiropractic adjustments and related wellness care. The business model is designed to provide convenient, accessible care through walk-in visits, membership plans and prepaid packages, with an emphasis on transparent pricing and extended operating hours.